HEALTH● LOWAug 28 · Aug 28, 2026, 12:18 PM
Amgen, Astra post late-stage trial win for asthma drug Tezspire in swallowing disorder
Seeking Alpha Tech · global
Amgen and Astra have achieved a late-stage trial win for their asthma drug Tezspire in treating a swallowing disorder. This development indicates potential progress in medical treatment for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoAfter two deaths: malaria warning in FrankfurtEuroNews [en]HEALTH1h agoDengue spread neither unusual nor alarming this year: Tamil Nadu Directorate of Public HealthThe HinduHEALTH1h agoMaharashtra FDA Commissioner made recommendation to NPPA on pricing gap of hospital consumablesThe HinduHEALTH2h agoOceania Country Declares National HIV CrisisChannels TV